TF Market Research



Title:

Pharmaceutical Companies Analysis - Chugai Pharmaceutical Co

Price:$680.00
Publication Date:Oct 01, 1998
Source:ESPICOM BUSINESS INTELLIGENCE
Author:Espicom
Company:CHUGAI PHARMACEUTICAL CO. LTD.
Length:34 Pages
Industry:BIOTECHNOLOGY, MEDICAL SUPPLY, PHARMACEUTICALS
Format:Adobe Acrobat Adobe Acrobat

Sections
TitleStarting PageNumber of Pages
Main Therapeutic Areas11
Profile Overview11
Main R&D Areas11
Profit And Loss12
Balance Sheet21
Financial Commentary52
Cash Flows22
Recent History/Corporate Strategy72
Recent History/Corporate Strategy33
Agreements By Company98
Acquisitions/Divestitures51
Structure And Activities173
Colorado MEDtech Inc - Agreements51
Geographical Breakdown193
Chiron Corporation - Agreements52
Product Portfolio245
Molecular Biosystems Inc - Agreements61
Research And Development287
Schering-Plough - Agreements61
Kirin Brewery Co Ltd - Agreements71
Yamanouchi - Agreements71
Rhone-Poulenc Rorer - Agreements81
Organon Teknika And Stanford University - Agreements81
Gliatech Inc - Agreements81
Trega Biosciences Inc - Agreements91
AMRAD Pharmaceuticals Pty Ltd - Agreements92
IDEC Pharmaceuticals Corporation - Agreements101
Mikasa Seiyaku - Agreements101
Prolifix Ltd - Agreements101
Novartis Pharma KK - Agreements101
GelTex Pharmaceuticals Inc - Agreements101
Choongwae Pharma - Agreements111
Reaads Medical Products Inc - Agreements111
Genta Inc - Agreements111
Merck KGaA111
Italfarmaco SpA121
Lonza Biologics Plc - Discontinued Agreement121
Structure And Activities122
Manufacturing And Capital Expenditure132
Geographical Breakdown142
Subsidiaries152
Joint-Venture Companies162
Haematological171
Epogin181
Markets/Sales181
Indications191
Cardiovascular And Respiratory - Clinical Trials191
Sigmart - Clinical Trials191
Rhythmodan - Clinical Trials201
Preran - Clinical Trials201
Metabolic - Clinical Trials201
Alfarol - Clinical Trials201
Gastrointestinal - Clinical Trials201
Ulcerlmin - Clinical Trials201
Central Nervous System - Clinical Trials211
Amoban - Clinical Trials211
Antibiotics - Clinical Trials211
Keiten - Clinical Trials211
Oncology - Clinical Trials211
Picibanil - Clinical Trials211
Taxotere - Clinical Trials211
Research And Development215
AVS - Clinical Trials251
Suvenil (NRD 101) - Clinical Trials261
Oct - Clinical Trials261
Raloxifene (LY139481) - Clinical Trials261
ED-71 - Clinical Trials271
MX-68 - Clinical Trials271
Letrozole - Clinical Trials271
MRA - Clinical Trials271
GM-611 - Clinical Trials271
FS069/Oralex - Clinical Trials271
Tables
TitleStarting PageNumber of Pages
Principal Operating Results 1993-9811
Main Therapeutic And R&D Areas11
Financial Indicators 1993-9812
Major Products171
Sales By Business Area 1993-98161
R&D Pipeline September 1998231
Breakdown Of Sales By Therapeutic Area 1993-98212
Sales Of Major Pharmaceuticals 1993-98221
Major Products231
Nicorandil Status In Various Markets 1996-98261
R&D Pipeline, September 1998292
Major Healthcare Subsidiaries And Associated Companies341
Graphs
TitleStarting PageNumber of Pages
Sales, Costs And Operating Profit 1993-9831
Profitability And Research Ratios 1993-9831
R&D Expenditure And Capital Expenditure 1993-9831
Current Assets, Liabilities And Ratio 1993-9841
Assets, Cash And Liquidity 1993-9841
Employees And Productivity 1993-9841
Sales By Business Area 1993-98161
Sales By Business Area 1998171
Sales By Therapeutic Area 1998221
Sales Of Top 5 Products 1993-98231
Sales By Major Product 1998231
Purchase Report
Price: $680.00

Looking For Something Else?


TF Market Research

TF Market Research® reports contain in-depth primary research and statistics, market trends, forecasts, segment analysis and much more from over 100 top con sulting, market research and business publishing sources. The service is updated daily.

  about us | contact us | public company index | private company index | pcan | widget | your privacy rights | terms & conditions  

Copyright © 2008 Alacra, Inc., 100 Broadway, Suite 1100, New York, NY 10005. All rights reserved.
Reproduction in whole or in part in any form or medium without express written permission is prohibited.